Neurocrine Biosciences董事Sherwin出售价值160万美元股票
圣地亚哥讯—市值114亿美元、财务状况稳健且流动比率为3.4的生物制药公司Neurocrine Biosciences Inc. (NASDAQ: NBIX )的董事Stephen A.
Neurocrine Biosciences director Sherwin sells $1.6m in stock
Stephen A. Sherwin, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), a $11.4 billion biopharmaceutical company with strong financials and a healthy current ratio of 3.4, sold 13,831 shares of ...